The Effects of Pentoxifylline on PAI-1 in an Obese Population
NCT00770328
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
37
Enrollment
OTHER
Sponsor class
Conditions
Obesity
Interventions
DRUG:
Pentoxifylline
DRUG:
Placebo
Sponsor
Vanderbilt University